AstraZeneca, AI biologics firm Absci tie up on cancer drug

cafead

Administrator
Staff member
  • cafead   Dec 03, 2023 at 09:32: PM
via Anglo-Swedish drugmaker AstraZeneca (AZN.L) has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm Absci (ABSI.O) to design an antibody to fight cancer, Absci said in a statement on Sunday.

article source